Alkermes and Fred Hutch to work on Keytruda combination treatment
Alkermes to work collaboratively with the Fred Hutchinson Cancer Research Center on the clinical development of a drug candidate as a combination treatment alongside Keytruda.
Archives for October 22, 2019
Sartorius in $750m swoop for Danaher Life Science businesses
Sartorius is set to acquire three biopharma businesses from Danaher, once the latter company concludes its deal for GE Biopharma.
Mesoblast and Lonza agree commercial manufacture of allogeneic cell therapy
Lonza will manufacture mesoblast’s lead cell therapy ahead of a planned US market launch, which could occur next year.